-transparent.png){kind=logo}
Intravenous injection of synthetic thyrotropin-releasing hormone (TRH) resulted in a significant and dose-related increase in plasma growth hormone (GH) in the urethane anesthetized rat. The minimum effective does of TRH was 40 ng per 100 g body wt when administered intravenously. The maximum responses of plasma GH to TRH were observed at 5 min following TRH, whereas those of plasma TSH were obtained at 10 min. Pretreatment with either T3 (50 mug/100 g body wt ip) significantly suppressed both plasma GH and TSH responses to TRH. The GH release induced by TRH was significantly inhibited by somatostatin (5 mug/100 g body wt iv) which was injected 5 min and immediately before the injection of TRH.
Y Kato, and
K Chihara, and
K Maeda, and
S Ogo, and
Y Okanishi
June 1979,
Life sciences,
Y Kato, and
K Chihara, and
K Maeda, and
S Ogo, and
Y Okanishi
July 1985,
Endocrinology,
Y Kato, and
K Chihara, and
K Maeda, and
S Ogo, and
Y Okanishi
November 1983,
Neuroendocrinology,
Y Kato, and
K Chihara, and
K Maeda, and
S Ogo, and
Y Okanishi
June 1989,
Acta psychiatrica Scandinavica,
Y Kato, and
K Chihara, and
K Maeda, and
S Ogo, and
Y Okanishi
September 1973,
The Journal of clinical endocrinology and metabolism,
Y Kato, and
K Chihara, and
K Maeda, and
S Ogo, and
Y Okanishi
June 1990,
Biological psychiatry,
Y Kato, and
K Chihara, and
K Maeda, and
S Ogo, and
Y Okanishi
June 1985,
Endocrinologia japonica,
Y Kato, and
K Chihara, and
K Maeda, and
S Ogo, and
Y Okanishi
March 1989,
General and comparative endocrinology,
Y Kato, and
K Chihara, and
K Maeda, and
S Ogo, and
Y Okanishi
February 1987,
Biological psychiatry,
Y Kato, and
K Chihara, and
K Maeda, and
S Ogo, and
Y Okanishi
February 1990,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
